SCHEMBL235057

SCHEMBL235057

[C]1=CCNSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22960 0.56
SCHEMBL347419 0.43
SCHEMBL61422 0.37
SCHEMBL570870 0.34
SCHEMBL4175824 0.34
SCHEMBL29889134 0.24
SCHEMBL29612863 0.24
SCHEMBL6559802 0.24
SCHEMBL31228748 0.24
Methane SCHEMBL23304207 0.17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116931-A1 PROTEIN KINASE MKK4 INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH HEPAREGENIX GMBH (DE) 2024-04-11 US disclosed
US-11912701-B2 Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death HEPAREGENIX GMBH (DE) 2024-02-27 US disclosed
US-11858927-B2 Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death HEPAREGENIX GMBH (DE) 2024-01-02 US disclosed
CN-111788195-B Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death 海帕瑞吉尼克斯股份有限公司 2023-11-21 CN disclosed
WO-2023194443-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER HEPAREGENIX GMBH (DE) 2023-10-12 WO disclosed
US-11731968-B2 Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death HEPAREGENIX GMBH (DE) 2023-08-22 US disclosed
CN-110291089-B Protein kinase inhibitors for promoting liver regeneration or reducing or preventing liver cell death 海帕瑞吉尼克斯股份有限公司 2022-05-27 CN disclosed
US-11040027-B2 Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death HEPAREGENIX GMBH (DE) 2021-06-22 US disclosed
EP-3823968-A1 PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH HepaRegeniX GmbH (DE) 2021-05-26 EP disclosed
EP-3810139-A1 TRICYCLIC PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH HepaRegeniX GmbH (DE) 2021-04-28 EP disclosed
US-6440899-B1 CROP HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-08-27 US disclosed
CN-1358186-A Tricyclic benzoylcylohexanedione derivatives BASF AG (DE) 2002-07-10 CN disclosed
EP-0929548-B1 SUBSTITUTED CARBAMOYL TRIAZOLES AND THEIR USE AS HERBICIDES BASF AG (DE) 2002-06-26 EP disclosed
CN-1353685-A Process for preparing 2,2,4, 4-tetra-substituted 1,3, 5-cyclohexanetriones BASF AG (DE) 2002-06-12 CN disclosed
US-6352959-B1 HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-03-05 US disclosed
US-6326333-B1 HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-12-04 US disclosed
US-6265352-B1 Substituted carbamoyl triazoles and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2001-07-24 US disclosed
US-6165944-A 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2000-12-26 US disclosed
EP-0958292-A1 4-(3-HETEROCYCLYL-1-BENZOYL)PYRAZOLES AND THEIR USE AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1999-11-24 EP disclosed
WO-1998031682-A1 4-(3-HETEROCYCLYL-1-BENZOYL)PYRAZOLES AND THEIR USE AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1998-07-23 WO disclosed